Cyclosporins to treat Alzheimer's disease

Details for Australian Patent Application No. 2009210375 (hide)

Owner Novartis AG

Inventors Gaither, Larry Alexander; Cohen, Dalia

Agent Davies Collison Cave

Pub. Number AU-A-2009210375

Parent 2005261838

Filing date 17 August 2009

Wipo publication date 10 September 2009

International Classifications

A61K 38/13 (2006.01) Medicinal preparations containing peptides

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07K 7/64 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

3 September 2009 Complete Application Filed

10 September 2009 Application Open to Public Inspection

  Published as AU-A-2009210375

1 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009210376-Rail car suspension damping

2009210374-Reliability detection of channel quality indicator (CQI) and application to outer loop power control